Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Merck, sharp & Dohme (Human Health) Ltd

Femme et Homme Max 99 ans
Merck, sharp & Dohme (Human Health) Ltd MAJ Il y a 4 ans

A Phase IIa, Multicenter, Double-Blind, Randomized, Active-Controlled, Parallel-Arm Clinical Trial to Study the Efficacy and Safety of MK-0941 Compared to Sulfonylurea in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Therapy After 6 weeks of treatment, to assess the effect of the addition of MK 0941 compared with the addition of glimepiride on 24-hour weighted mean glucose (24-hour WMG).

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations